ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PHAT Phathom Pharmaceuticals Inc

10.04
0.28 (2.87%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Phathom Pharmaceuticals Inc PHAT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.28 2.87% 10.04 09:00:00
개장가 저가 고가 종가 전일 종가
10.35 9.84 10.37 10.04 9.76
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202421:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/04/202421:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/03/202421:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
08/03/202406:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/03/202422:06EDGAR2Form 8-K - Current report
07/03/202422:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29/02/202422:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13/02/202422:05EDGAR2Form 8-K - Current report
13/02/202422:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31/01/202422:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
23/01/202410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:05EDGAR2Form 8-K - Current report
14/12/202322:05EDGAR2Form 8-K - Current report
14/12/202322:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06/12/202322:05EDGAR2Form 8-K - Current report
06/12/202322:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28/11/202322:06EDGAR2Form 8-K - Current report
28/11/202322:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
20/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
10/11/202306:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:05EDGAR2Form 8-K - Current report
09/11/202322:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
09/11/202309:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202305:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202306:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
02/11/202306:06EDGAR2Form 8-K - Current report
02/11/202306:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202321:05EDGAR2Form 8-K - Current report
30/10/202321:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202321:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/09/202321:05EDGAR2Form 8-K - Current report
26/09/202321:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/09/202321:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/08/202321:07EDGAR2Form 8-K - Current report
21/08/202321:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
11/08/202305:02EDGAR2Form 8-K - Current report
10/08/202321:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202321:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
18/07/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202305:04EDGAR2Form 8-K - Current report
18/07/202305:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/06/202322:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
12/06/202321:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
10/06/202305:01GLOBEPhathom Pharmaceuticals Announces Closing of Underwriters’..
09/06/202318:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
07/06/202318:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
02/06/202318:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
01/06/202321:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
30/05/202318:00PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..

최근 히스토리

Delayed Upgrade Clock